rdf:type |
|
lifeskim:mentions |
umls-concept:C0013216,
umls-concept:C0036525,
umls-concept:C0175630,
umls-concept:C0225336,
umls-concept:C0681842,
umls-concept:C0871261,
umls-concept:C1522484,
umls-concept:C1527249,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
pubmed:issue |
3
|
pubmed:dateCreated |
2011-8-26
|
pubmed:abstractText |
Standardized enumeration of CEC counts is required to minimize variability and allow cross-studies comparisons. The purpose of this paper is to identify CEC threshold proposal, by CellSearch system, for determining response to bevacizumab-based chemotherapy in metastatic colorectal cancer.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1432-0843
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
68
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
763-8
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:21170650-Adolescent,
pubmed-meshheading:21170650-Adult,
pubmed-meshheading:21170650-Aged,
pubmed-meshheading:21170650-Angiogenesis Inhibitors,
pubmed-meshheading:21170650-Antibodies, Monoclonal,
pubmed-meshheading:21170650-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:21170650-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:21170650-Cell Count,
pubmed-meshheading:21170650-Cell Separation,
pubmed-meshheading:21170650-Colorectal Neoplasms,
pubmed-meshheading:21170650-Disease-Free Survival,
pubmed-meshheading:21170650-Endothelial Cells,
pubmed-meshheading:21170650-Female,
pubmed-meshheading:21170650-Fluorouracil,
pubmed-meshheading:21170650-Humans,
pubmed-meshheading:21170650-Kaplan-Meier Estimate,
pubmed-meshheading:21170650-Leucovorin,
pubmed-meshheading:21170650-Male,
pubmed-meshheading:21170650-Middle Aged,
pubmed-meshheading:21170650-Neoplasm Metastasis,
pubmed-meshheading:21170650-Organoplatinum Compounds,
pubmed-meshheading:21170650-Predictive Value of Tests,
pubmed-meshheading:21170650-Prospective Studies,
pubmed-meshheading:21170650-Regression Analysis,
pubmed-meshheading:21170650-Survival Analysis,
pubmed-meshheading:21170650-Young Adult
|
pubmed:year |
2011
|
pubmed:articleTitle |
Circulating endothelial cells predict for response to bevacizumab-based chemotherapy in metastatic colorectal cancer.
|
pubmed:affiliation |
Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|